JP2002501613A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501613A5
JP2002501613A5 JP1998544536A JP54453698A JP2002501613A5 JP 2002501613 A5 JP2002501613 A5 JP 2002501613A5 JP 1998544536 A JP1998544536 A JP 1998544536A JP 54453698 A JP54453698 A JP 54453698A JP 2002501613 A5 JP2002501613 A5 JP 2002501613A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998544536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501613A (ja
JP4183757B2 (ja
Filing date
Publication date
Priority claimed from AUPO5736A external-priority patent/AUPO573697A0/en
Application filed filed Critical
Publication of JP2002501613A publication Critical patent/JP2002501613A/ja
Publication of JP2002501613A5 publication Critical patent/JP2002501613A5/ja
Application granted granted Critical
Publication of JP4183757B2 publication Critical patent/JP4183757B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54453698A 1997-03-20 1998-03-20 子宮内膜ガンの検出 Expired - Fee Related JP4183757B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU5736 1997-03-20
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer
PCT/AU1998/000189 WO1998042865A1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007001867A Division JP2007202556A (ja) 1997-03-20 2007-01-09 子宮内膜ガンの検出

Publications (3)

Publication Number Publication Date
JP2002501613A JP2002501613A (ja) 2002-01-15
JP2002501613A5 true JP2002501613A5 (enExample) 2005-11-10
JP4183757B2 JP4183757B2 (ja) 2008-11-19

Family

ID=3800039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54453698A Expired - Fee Related JP4183757B2 (ja) 1997-03-20 1998-03-20 子宮内膜ガンの検出
JP2007001867A Withdrawn JP2007202556A (ja) 1997-03-20 2007-01-09 子宮内膜ガンの検出

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007001867A Withdrawn JP2007202556A (ja) 1997-03-20 2007-01-09 子宮内膜ガンの検出

Country Status (14)

Country Link
US (1) US6607894B1 (enExample)
EP (1) EP0979304B1 (enExample)
JP (2) JP4183757B2 (enExample)
KR (1) KR20010006344A (enExample)
CN (1) CN1257550A (enExample)
AT (1) ATE331039T1 (enExample)
AU (1) AUPO573697A0 (enExample)
CA (1) CA2284099C (enExample)
DE (1) DE69835010T2 (enExample)
ES (1) ES2268767T3 (enExample)
MY (1) MY119567A (enExample)
NZ (1) NZ337868A (enExample)
WO (1) WO1998042865A1 (enExample)
ZA (1) ZA982403B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322023A1 (en) * 1998-03-05 1999-09-10 John D. Burczak A novel method of detecting and monitoring endometrial and uterine cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
DK1782068T3 (da) * 2004-07-23 2010-08-02 Ct De Rech Public De La Sante Overvågning af hjertesvigt
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
EP1846558A2 (en) * 2005-02-09 2007-10-24 Genentech, Inc. Inhibiting her2 shedding with matrix metalloprotease antagonists
WO2007086915A2 (en) * 2005-05-12 2007-08-02 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
RU2304782C1 (ru) * 2005-12-28 2007-08-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ прогнозирования рецидива эндометриоидной кисты яичника
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2419736B1 (en) * 2009-04-16 2014-01-29 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
CN102549169B (zh) * 2009-07-24 2016-02-24 吉第克生物技术有限公司 子宫内膜癌的标记物
EP2558506B1 (en) 2010-04-16 2019-06-26 Momenta Pharmaceuticals, Inc. Tissue targeting
RU2430371C1 (ru) * 2010-04-26 2011-09-27 Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ дифференциальной диагностики и прогноза миомы и рака эндометрия
BR112012031906A2 (pt) 2010-06-17 2016-08-23 Momenta Pharmaceuticals Inc métodos e composições para modular o crescimento de cabelo e pelos.
US8455624B2 (en) * 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
EP3249399A1 (en) * 2011-09-22 2017-11-29 Memorial Sloan-Kettering Cancer Center Detecting ovarian cancer
EP2809801B1 (en) * 2012-01-31 2018-07-25 Speiser, Paul Non-invasive cancer diagnosis
EP3003324A4 (en) 2013-05-28 2017-01-25 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
EP3164717B1 (en) * 2014-07-02 2019-08-28 Bionomics Limited Predictive biomarkers
CA2975737A1 (en) * 2015-02-06 2016-08-11 Quest Diagnostics Investments Llc Compositions and methods for determining endometrial cancer prognosis
CA3286798A1 (en) * 2016-05-04 2025-10-30 Fundacio Hospital Universitari Vall D'hebron-Institut De Recerca Markers of endometrial cancer
IN202021002695A (enExample) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
DE69332930T2 (de) * 1992-11-16 2004-02-26 Cancer Research Fund Of Contra Costa, Walnut Creek Peptide mit breiter neoplastischer spezifizität

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509635A5 (enExample)
JP2000507042A5 (enExample)
JP2000509912A5 (enExample)
JP2000509637A5 (enExample)
JP2000509942A5 (enExample)
JP2001511276A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)